Compare LMRI & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LMRI | BVS |
|---|---|---|
| Founded | 2018 | 2011 |
| Country | United States | United States |
| Employees | 4335 | N/A |
| Industry | Medical Specialities | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 781.1M | 716.8M |
| IPO Year | N/A | 2016 |
| Metric | LMRI | BVS |
|---|---|---|
| Price | $8.77 | $9.17 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | ★ $20.75 | $14.00 |
| AVG Volume (30 Days) | ★ 1.2M | 662.0K |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 163.46 |
| EPS | N/A | ★ 0.04 |
| Revenue | N/A | ★ $568,087,000.00 |
| Revenue This Year | $6.35 | $7.52 |
| Revenue Next Year | $5.61 | $7.06 |
| P/E Ratio | ★ N/A | $230.00 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.45 | $5.81 |
| 52 Week High | $19.45 | $11.25 |
| Indicator | LMRI | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 53.90 | 47.74 |
| Support Level | $7.25 | $8.43 |
| Resistance Level | $10.53 | $9.24 |
| Average True Range (ATR) | 0.56 | 0.54 |
| MACD | 0.20 | 0.01 |
| Stochastic Oscillator | 87.93 | 45.68 |
Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities, including MRI, CT, PET, X-ray, ultrasound, and mammography. Its products and operations are managed and reported in two operating segments: Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The professional services segment generates revenue from interpreting imaging studies conducted by other parties, mainly hospital imaging departments. The majority of revenue is generated by the Outpatient segment, which performs imaging studies and provides radiologists' interpretations of those studies.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.